iSpeak Blog
The 2022 revision of EU GMP Annex 1 has significantly increased regulatory focus on sterility assurance, contamination control strategies (CCS), and the technical justification of CQV activities for sterile manufacturing facilities. Concurrently, life sciences capital projects continue to face increasing pressure to reduce delivery timelines, driving interest in digital and AI–enabled tools to...